We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 7,694 results
  1. Nonlinear Methods for the Investigation of Psychotic Disorders

    The basic aspects of nonlinear dynamics theory’s utility and impact on understanding psychotic disorders are reviewed and discussed in this chapter....
    Alexandra Korda, Marina Frisman, ... Stefan Borgwardt in Computational Neuroscience
    Protocol 2023
  2. Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medication

    Background

    The neurobiology of psychotic depression is not well understood and can be confounded by antipsychotics. Magnetic resonance spectroscopy...

    Hideaki Tani, Iska Moxon-Emre, ... Aristotle N. Voineskos in Brain Imaging and Behavior
    Article Open access 02 November 2023
  3. Psychotic Disorders (“Schizophrenia”)

    After reading the chapter, the reader should be able to name the symptoms of schizophrenia as well as its treatment options and to classify different...
    Florian Schlagenhauf, Philipp Sterzer in Psychoneuroscience
    Chapter 2023
  4. QEEG and ERP Biomarkers of Psychotic and Mood Disorders and Their Treatment Response

    Electroencephalography (EEG) is widely accessible and can be relatively easily applied in clinical settings. This chapter is focused on selected...
    Sevdalina Kandilarova, Igor Riečanský in Computational Neuroscience
    Protocol 2023
  5. Neuronal pentraxin-2 (NPTX2) serum levels during an acute psychotic episode in patients with schizophrenia

    Background

    Neuronal pentraxin-2 (NPTX2, an immediate-early gene), which regulates synapse activity and neuroplasticity, plays an essential role in the...

    Diğdem Göverti, Nihan Büyüklüoğlu, ... Erol Göka in Psychopharmacology
    Article 28 April 2022
  6. Blood and CSF anti-neuronal antibodies testing in psychotic syndromes: a retrospective analysis from a tertiary psychiatric hospital

    A Consensus of Psychoimmunology Experts ( Pollak et al., 2019) established a set of red flags and proposed diagnostic criteria for psychosis of...

    Joana Lopes, Maria João Malaquias, ... Ana Paula Correia in Immunologic Research
    Article 31 January 2024
  7. A Pilot Study of Adolescents with Psychotic Experiences: Potential Cerebellar Circuitry Disruption Early Along the Psychosis Spectrum

    A berrant connectivity in the cerebellum has been found in psychotic conditions such as schizophrenia corresponding with cognitive and motor deficits...

    Caoimhe Gaughan, Anurag Nasa, ... Darren William Roddy in The Cerebellum
    Article Open access 23 June 2023
  8. Psychotic Disorders in the Veterans of Local Wars

    Objectives. To determine the frequency of leading psychopathological syndromes, dynamics, and comorbidities of schizophrenia and other endogenous...

    A. M. Reznik, T. S. Syunyakov, ... Yu. L. Martynyuk in Neuroscience and Behavioral Physiology
    Article 18 February 2021
  9. Genetic Basis of Psychotic Illnesses: A Comprehensive Overview

    Psychotic illness is a major health burden at the present world. Common psychotic disorders like autism spectrum disorders and schizophrenia...
    Md. Abdul Aziz, Tahmina Akter, ... Mohammad Safiqul Islam in Autism Spectrum Disorder and Alzheimer's Disease
    Chapter 2021
  10. Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia

    Rationale

    Ketamine may model aspects of schizophrenia arising through NMDA receptor activity deficits. Although acute ketamine can induce effects...

    Robert A. Chesters, Fiona Pepper, ... James M. Stone in Psychopharmacology
    Article Open access 06 July 2021
  11. Psychotic Disorders in Epilepsy: Do They Differ from Primary Psychosis?

    Any attempt to compare the definitions of symptoms listed for “primary psychoses” with those adopted in studies of psychoses in patients with...
    Chapter 2021
  12. Consumption of Cannabis: A Risk Factor or a Therapeutic Agent for Patients with Schizophrenia

    Schizophrenia is a complex disorder signified by both positive and negative symptoms that include delusion, apathy, and cognitive dysfunction....
    Anika Zainab, Dania Shabbir, ... Asim Mehmood in Cognizance of Schizophrenia:: A Profound Insight into the Psyche
    Chapter 2023
  13. Quantitative EEG in Patients with Schizophrenia

    Schizophrenia is a chronic mental illness with a diverse clinical picture. Diagnosis is based on clinical symptoms as well as their duration over...
    Georgi Panov in Computational Neuroscience
    Protocol 2023
  14. Implementation of CYP2D6 copy-number imputation panel and frequency of key pharmacogenetic variants in Finnish individuals with a psychotic disorder

    We demonstrate that CYP2D6 copy-number variation (CNV) can be imputed using existing imputation algorithms. Additionally, we report frequencies of...

    Katja Häkkinen, Johanna I. Kiiski, ... Ari V. Ahola-Olli in The Pharmacogenomics Journal
    Article Open access 23 February 2022
  15. Inter-rater reliability of subthreshold psychotic symptoms in individuals with 22q11.2 deletion syndrome

    Background

    Pathways leading to psychosis in 22q11.2 deletion syndrome (22q11.2DS) have been the focus of intensive research during the last two...

    Tyler M. Moore, Deby Salzer, ... Doron Gothelf in Journal of Neurodevelopmental Disorders
    Article Open access 14 June 2021
  16. Religious hallucinations in Lebanese patients with schizophrenia and their association with religious co**

    Purpose

    to evaluate the relationship between religious hallucinations and religious co** among Lebanese patients with schizophrenia.

    ...
    Rabih Fares, Jean-Marc Rabil, ... Souheil Hallit in BMC Research Notes
    Article Open access 02 March 2023
  17. Evidence of innate immune dysfunction in first-episode psychosis patients with accompanying mood disorder

    Background

    Inflammation and increases in inflammatory cytokines are common findings in psychiatric disorders such as schizophrenia (SCZ), bipolar...

    Heather K. Hughes, Houa Yang, ... Paul Ashwood in Journal of Neuroinflammation
    Article Open access 03 December 2022
  18. Efficacy of low-dose risperidone in combination with sertraline in first-episode drug-naïve patients with schizophrenia: a randomized controlled open-label study

    Objective

    Despite advances in pharmacology, the treatment of schizophrenia (SZ) remains a challenge due to relapse after antipsychotic discontinuation...

    **aoe Lang, Mei Xue, ... **angyang Zhang in Journal of Translational Medicine
    Article Open access 04 July 2023
  19. Neuroimaging (Resting-State fMRI) and Neuropsychological Characteristics of Non-Converted Patients from a Group at Clinical High Risk for Schizophrenia

    The aim of the present study was, within the framework of the concept of “clinical high risk for psychosis,” to identify functional characteristics...

    I. S. Lebedeva, Ya. R. Panikratova, ... V. G. Kaleda in Neuroscience and Behavioral Physiology
    Article 01 October 2023
Did you find what you were looking for? Share feedback.